4 results found
AbbVie’s $63 million merger with Allergan is well-positioned for unconditional antitrust clearance in Brazil, MLex has learned.
Pfizer, Celgene's Brazilian subsidiaries, others, queried about substitutes in AbbVie-Allergan dealBrazilian subsidiaries of Pfizer, Celgene, Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson and UCB were asked by the national competition authority reviewing the AbbVie-Allergan deal whether there are close substitutes for medicines to treat Crohn’s disease, noninfectious uveitis and ulcerative colitis.
Walmart saw its plans to buy crowdsourced, on-demand delivery marketplace Cornershop MX potentially go down the drain with the Mexican competition authority's decision to block the deal because it would likely undermine companies operating in the same markets.
The deal between drugmakers Pfizer and Aspen Pharmacare should be approved by the Brazilian antitrust agency, according to a federal court ruling seen by MLex. The deadline suspension the agency declared for the case until its governing body resumes activities should also be voided, the judge said.